Hers markets weight care to women through a combination of clinical access, medication options and app support. That positioning may make the service feel approachable, but the important decisions remain individual: treatment suitability, the full recurring cost and the route to clinical follow-up.
The current offer should not be read as a universal prescription for menopause-related weight changes or a guarantee that every woman qualifies. A useful review keeps the advertised support features separate from the clinical assessment that determines a treatment plan.
What the service actually offers
Hers lists branded GLP-1 options and describes care-team messaging, a personalized plan and tracking tools as membership features. The service can be evaluated for convenience without assuming that marketing directed toward women establishes superior outcomes for women. Bring reproductive plans, other medicines and relevant medical history to the clinician through the secure intake.
Read the bill in full
The page’s price footnote separates medication from a required membership: $39 for the first month, automatically renewing at $149 per month afterward. Compare the combined charge for the medication and membership you actually choose. A treatment’s displayed starting price may have its own conditions; ask which amounts change after an introductory period and which charges continue during a pause.
After the first order
A useful follow-up plan has a named route for symptom questions and a separate route for account administration. App messaging can support that plan, but we did not test response times or the quality of clinical conversations. Before a refill, ask whether an updated assessment is needed and how a clinician communicates a decision to continue, modify or discontinue the prescription.
Keep a useful paper trail
If you need to end service, distinguish a medication order from the underlying membership. Ask for written confirmation covering both where appropriate. Keep the dates of the original authorization, the request to cancel and the reply. For a benefits-account question, obtain the receipt and consult your plan administrator; a marketing reference to HSA or FSA use does not determine reimbursement for every charge.
- What is the combined cost after introductory pricing ends?
- Which clinical channel should I use between refills?
- What remains active if I pause or stop medication?
Our reading of the trade-off
Hers may fit a reader who wants a women-focused service interface and ongoing digital support. The trade-off is that the total price requires adding separate components. Consider whether those service features will be useful to you, and compare them with the actual features in a medication-inclusive program rather than comparing two unrelated headline prices.
What this review can establish
This is a desk review of published information, not a treatment trial, mystery-shopper order or verified complaint history. A provider’s website can establish what it advertises; it cannot show how reliably an individual request will be handled. We have not measured this service’s response time, refund performance or patient outcomes.
The prescription itself needs a separate clinical assessment. FDA-approved products and compounded preparations have different evidence and regulatory status. Compounded drugs are not FDA-approved, and a branded drug’s trial results cannot be assigned to a provider’s compound. Bring medication and safety questions to the prescribing clinician and dispensing pharmacist.
Turn the question into a useful message.
Choose a billing, delivery, account or treatment topic. Our support note builder gives you a short checklist and a draft to take to the right team.
Build your noteSources for this file
Provider sources describe advertised services; they do not establish delivery performance or patient outcomes. Medical sources support the educational context. Review date: 2026-10-05.